The New York Academy of Sciences
New York, NY
Tuesday, September 25, 2018
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder for which there is a major unmet therapeutic need. Limited success from current translational models and amyloid-centric clinical trials highlight the need for broader therapeutic strategies. Looking beyond amyloid and tau as direct avenues to modify AD pathology, the field has turned to a growing body of genetic and human biology evidence that supports a role for the innate immune system as a key modifier of AD risk and progression. This one-day symposium will present recent developments in our understanding of how innate immune processes, such as those controlled by CNS-resident microglia, impact the pathobiology of AD. Moreover, the program will explore the dynamic mechanisms at the intersection of neurology and immunology that have emerged as ‘omics technologies have supplanted classical views of neuro-inflammation, with the goal of targeting the innate immune system in the CNS for next-generation AD therapeutics.
AAAS and the Dana Foundation
Washington, DC
Thursday, October 04, 2018
This program will
present the latest theories about the causes of autism, both genetic and
nongenetic, and also provide an overview of what are currently considered the
best treatment options for both children and adults. Moderated by Barry Gordon of Johns Hopkins Medical Institution, featured panelists are: Geraldine Dawson of Duke University, Daniel Geschwind of UCLA, and Janine LaSalle of UC Davis.
The New York Academy of Sciences
New York, NY
Tuesday, October 09, 2018
This symposium will bring together scientists, clinicians, other healthcare professionals, and policy makers across academia, industry, and government sectors to discuss the latest advances in understanding the underlying neurobiology of mental illness — including epigenetic, molecular, and neuroimmunological mechanisms. Speakers will discuss research on topics such as molecular overlap in brain disorders, stigma, the neuroimmunology of mood disorders, post-traumatic stress disorder (PTSD), suicidal behavior, and bipolar disorder. In addition to exploring the basic science underlying these illnesses, the symposium will also focus on the translations of these findings into improved pharmacological, psychotherapeutic, and other interventions for mental health.
The International Center for Biomedicine
Santiago, Chile
Friday, October 12, 2018 - Saturday, October 13, 2018
This is an international conference directed to the medical community, scientists, and people concerned with Alzheimer's disease (AD). The major theme is to explore cutting-edge research advances on this disease. AD is a multifactorial neurodegenerative disease, currently the principal cause of dementia in the elderly, characterized by a progressive cognitive impairment, associated to the neuroinflammatory process triggered by “damage signals.” Considering the multifactorial scenario in this pathology, currently no drugs are available as an effective therapy against AD. This Conference will present some of the most creative developments in our understanding of how neuroinflammation triggers AD, as well as innovative biomarkers as a diagnosis tool and novel therapeutic avenues. The emergency of natural bioactive compounds appears as a plausible avenue toward prevention and as co-adjuvants in the treatment of this disease. In this context, evidence-based nutraceutical compounds rely on some of the major advances in molecular genetics, epitranscriptomics, molecular biology, and modern pharmacology.
Brain & Behavior Research Foundation
Kaufman Music Center
Friday, October 26, 2018
Join the Brain & Behavior Research Foundation for a keynote talk from The Honorable Steven Leifman, Associate Administrative Judge, Criminal Division; and featured speaker Altha Stewart, M.D., President, American Psychiatric Association (APA), along with presentations on leading research discoveries across brain and behavior disorders by the Foundation’s 2018 Outstanding Achievement Prizewinners and two select Young Investigator Grantees.
Society for Neuroscience
San Diego, CA
Saturday, November 03, 2018 - Wednesday, November 07, 2018
SfN's 48th annual meeting, Neuroscience 2018, is the world's largest neuroscience conference for scientists and physicians devoted to understanding the brain and nervous system. SfN invites you to its renowned venue where neuroscientists collaborate and network with peers, learn from experts, explore the newest neuroscience tools and technologies, and discover great career opportunities. Neuroscience 2018 is November 3-7 at the San Diego Convention Center. Join more than 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.
Learning & the Brain
Boston, MA
Friday, November 16, 2018 - Sunday, November 18, 2018
Some education leaders, such as Yong Zhao and Sir Ken
Robinson, say it is time for schools to move beyond test scores and standards
and towards student-centered classrooms that develop the potential for
greatness that lies within each child. Current cognitive and psychological
sciences have discovered that the “science of greatness” is complex, involving
talents, practice, passion, interest, and hard work. But it is also finding
that greatness and extraordinary abilities are within the reach of all of us.
Discover what research on prodigies, savants, and geniuses teaches us about
child potential and the links between learning disorders, great talents, and
genius. Learn strategies to unlock your students’ potential, passions and
interests, talents, creativity, expertise, and extraordinary performance.
